Clinical Trial Update: Evaluation of an Oral Nutritional Supplement Containing AN777 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an oral nutritional supplement containing AN777 for malnutrition and sarcopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malnutrition
• Sarcopenia

Drugs mentioned

• AN777-containing oral nutritional supplement (AN777)

Snippet

Sponsor: Abbott Nutrition | Conditions: Malnutrition, Sarcopenia | Phase 3 | Status: COMPLETED